Clinical Trials

Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 190
  • Start Date: September 17, 2020
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled Study With Deferred Active Treatment to Investigate the Efficacy, Safety, and Pharmacokinetics of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus
Clinical Trial
  • Status: Enrolling by invitation
  • Intervention Type: Procedure
  • Participants: 30
  • Start Date: October 10, 2019
HBV DNA Replication in Hepatocytes in HBV and HDV Co-infection
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: October 2019
A Phase 2b, Open-Label, Randomized Study of the Safety, Tolerability, and Pharmacodynamic Activity of Lonafarnib With or Without Ritonavir in Patients Chronically Infected With Hepatitis Delta Virus (LOWR-5)
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 175
  • Start Date: May 31, 2019
A Multicenter, Open-label, Randomized Phase 2b Clinical Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Patients With Chronic Hepatitis Delta
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 150
  • Start Date: April 17, 2019
A Multicenter, Open-label, Randomized Phase 3 Clinical Study to Assess Efficacy and Safety of Bulevirtide in Patients With Chronic Hepatitis Delta
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 400
  • Start Date: December 1, 2018
A Phase 3, Matrix Design, Partially Double-Blind, Randomized Study of the Efficacy and Safety of 50 mg Lonafarnib/100 mg Ritonavir BID With and Without 180 mcg PEG IFN-alfa-2a for 48 Weeks Compared With PEG IFN-alfa-2a Monotherapy and Placebo Treatment in Patients Chronically Infected With Hepatitis Delta Virus Being Maintained on Anti-HBV Nucleos(t)Ide Therapy (D-LIVR)
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 500
  • Start Date: August 23, 2016
Chronic Hepatitis B Virus Infection in Zambia: a Prospective Clinical Cohort Study
Clinical Trial
  • Status: Recruiting
  • Participants: 1000
  • Start Date: November 2013
Hepatitis Delta Registry and Research Network- Observational Study
Clinical Trial
  • Status: Recruiting
  • Participants: 8000
  • Start Date: May 27, 1992
Evaluation of Patients With Liver Disease
Showing 1-9 of 9